http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0116558-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d269c8e41f178194d858c230c9f85e3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2001-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45f5776d838cf84860a5e6fd24d6d8e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e4dac378f2d32d93f30bbc8d2789c73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9dc2a2a108a99d6b02ccda866a0e7f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21215105fcbf34b6e07f8103d579ea40
publicationDate 2003-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0116558-A
titleOfInvention Pharmaceutical composition in tablet, amylodipine free base, method of treatment or prevention of hypertension, angina or cardiac congestion, process, process for purification of amlodipine free base and particulate amlodipine free base population
abstract "PHARMACEUTICAL COMPOSITION IN TABLETS, AMLODIPINE FREE BASE, METHOD OF TREATMENT OR PREVENTION OF HYPERTENSION, ANGINE OR CARDIAC CONGESTION, PROCESS, PROCESS FOR PURIFICATION OF FREE AMLODIPINE BASE POPULAS AND POPULAS BASE. An amlodipine-free base may be formulated in a dosage form suitable for oral administration, particularly a tablet, without excessive adherence or residue left in the tableting pad. The amlodipine free base may be in crystalline Form I or in the new Form II. Methods of manufacture and use of amlodipine free base are presented.
priorityDate 2000-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162

Total number of triples: 31.